Note 13. Stock-based Compensation

Stock-based compensation related to the Company’s stock plans was as follows (amounts in thousands):

​

During the three and nine months ended September 30, 2022, the Company capitalized approximately $0.1 million and $0.2 million, respectively, of stock-based compensation expense associated with the cost of developing software for internal use. During the three and nine months ended September 30, 2021, the Company capitalized approximately $0.1 million of stock-based compensation expense associated with the cost of developing software for internal use.

During the three and nine months ended September 30, 2022, the Company accrued $0.3 million and $0.23 million of stock compensation expense related to stock compensation earned but yet to be issued to agents. At September 30, 2022, a total of $0.5 million related to agent grant liabilities is included in accrued compensation.

At September 30, 2022, total unrecognized compensation cost related to non-vested restricted stock awards was $10.7 million, which is expected to be recognized over a period of approximately 1.37 years.

During the nine months ended September 30, 2022, the Company granted 662,217 restricted stock awards at a weighted-average grant-date fair value of $9.73.

During the nine months ended September 30, 2022 the Company granted 103,711 stock options at an exercise price of $8.22. At September 30, 2022, unrecognized compensation cost related to stock options was $0.4 million which will be recognized over 0.87 years.